FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:836-842 March 14, 2002 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 55-year-old obese white man has had frequent heartburn for more than 10 years. He has treated himself with a histamine H₂-receptor antagonist, which provides only partial relief. He decided to consult a physician after reading a magazine article warning that heartburn causes cancer of the esophagus. The patient has no other medical problems, dysphagia, or recent, unexplained weight loss, and . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Screening and Surveillance for Barrett's Esophagus

Treatment of Gastroesophageal Reflux Disease in Barrett's Esophagus

Dysplasia in Barrett's Esophagus

Natural History of High-Grade Dysplasia

Helicobacter pylori and Barrett's Esophagus

Areas of Uncertainty

Guidelines

Conclusions

Source Information

From the Dallas Department of Veterans Affairs Medical Center and the University of Texas Southwestern Medical Center at Dallas, Dallas.

Address reprint requests to Dr. Spechler at the Division of Gastroenterology (111B1), Dallas VA Medical Center, 4500 S. Lancaster Rd., Dallas, TX 75216.

References

This article has been cited by other articles:

• Zhai, R., Liu, G., Asomaning, K., Su, L., Kulke, M. H., Heist, R. S., Nishioka, N. S., Lynch, T. J., Wain, J. C., Lin, X., Christiani, D. C. (2008). Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis 29: 2330-2334 [Abstract] [Full Text]  
• Smith, M. S., Lightdale, C. J. (2008). Review: Barrett's esophagus and the increasing role of endoluminal therapy. Therapeutic Advances in Gastroenterology 1: 121-142 [Abstract]  
• Stoner, G. D., Wang, L.-S., Casto, B. C. (2008). Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries. Carcinogenesis 29: 1665-1674 [Abstract] [Full Text]  
• Zhang, H. Y., Zhang, X., Chen, X., Thomas, D., Hormi-Carver, K., Elder, F., Spechler, S. J., Souza, R. F. (2008). Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G470-G478 [Abstract] [Full Text]  
• Souza, R. F., Krishnan, K., Spechler, S. J. (2008). Acid, Bile, and CDX: the ABCs of making Barrett's metaplasia. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G211-G218 [Abstract] [Full Text]  
• Abrams, J. A. (2008). Review: Chemoprevention of esophageal adenocarcinoma. Therapeutic Advances in Gastroenterology 1: 7-18 [Abstract]  
• Larghi, A, Lecca, P G, Costamagna, G (2008). High-resolution narrow band imaging endoscopy. Gut 57: 976-986 [Full Text]  
• Yen, C.-J., Izzo, J. G., Lee, D.-F., Guha, S., Wei, Y., Wu, T.-T., Chen, C.-T., Kuo, H.-P., Hsu, J.-M., Sun, H.-L., Chou, C.-K., Buttar, N. S., Wang, K. K., Huang, P., Ajani, J., Hung, M.-C. (2008). Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma. Cancer Res. 68: 2632-2640 [Abstract] [Full Text]  
• Feagins, L. A., Zhang, H. Y., Zhang, X., Hormi-Carver, K., Thomas, T., Terada, L. S., Spechler, S. J., Souza, R. F. (2008). Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G411-G417 [Abstract] [Full Text]  
• Wang, T. D., Triadafilopoulos, G., Crawford, J. M., Dixon, L. R., Bhandari, T., Sahbaie, P., Friedland, S., Soetikno, R., Contag, C. H. (2007). Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy. Proc. Natl. Acad. Sci. USA 104: 15864-15869 [Abstract] [Full Text]  
• Zhang, H.-Y., Zhang, X., Hormi-Carver, K., Feagins, L. A., Spechler, S. J., Souza, R. F. (2007). In Non-neoplastic Barrett's Epithelial Cells, Acid Exerts Early Antiproliferative Effects through Activation of the Chk2 Pathway. Cancer Res. 67: 8580-8587 [Abstract] [Full Text]  
• Souza, R. F., Lunsford, T., Ramirez, R. D., Zhang, X., Lee, E. L., Shen, Y., Owen, C., Shay, J. W., Morales, C., Spechler, S. J. (2007). GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G19-G24 [Abstract] [Full Text]  
• Luthra, M. G., Ajani, J. A., Izzo, J., Ensor, J., Wu, T.-T., Rashid, A., Zhang, L., Phan, A., Fukami, N., Luthra, R. (2007). Decreased Expression of Gene Cluster at Chromosome 1q21 Defines Molecular Subgroups of Chemoradiotherapy Response in Esophageal Cancers. Clin. Cancer Res. 13: 912-919 [Abstract] [Full Text]  
• (2006). Dilemmas in managing Barrett's oesophagus. DTB 44: 69-72 [Abstract] [Full Text]  
• Keswani, R. N., Noffsinger, A., Waxman, I., Bissonnette, M. (2006). Clinical Use of p53 in Barrett's Esophagus.. Cancer Epidemiol. Biomarkers Prev. 15: 1243-1249 [Abstract] [Full Text]  
• Feagins, L. A., Susnow, N., Zhang, H. Y., Pearson, S., Owen, C., Schmalstieg, W. F., Terada, L. S., Spechler, S. J., Ramirez, R. D., Souza, R. F. (2006). Gain of allelic gene expression for IGF-II occurs frequently in Barrett's esophagus. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G871-G875 [Abstract] [Full Text]  
• Nishioka, N. S., Lauwers, G. Y. (2006). Case records of the Massachusetts General Hospital. Case 10-2006. A 66-year-old woman with Barrett's esophagus with high-grade dysplasia.. NEJM 354: 1403-1409 [Full Text]  
• Wongsurawat, V. J., Finley, J. C., Galipeau, P. C., Sanchez, C. A., Maley, C. C., Li, X., Blount, P. L., Odze, R. D., Rabinovitch, P. S., Reid, B. J. (2006). Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation.. Cancer Epidemiol. Biomarkers Prev. 15: 509-516 [Abstract] [Full Text]  
• Schottenfeld, D., Beebe-Dimmer, J. (2006). Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.. CA Cancer J Clin 56: 69-83 [Abstract] [Full Text]  
• Brundler, M-A, Harrison, J A, de Saussure, B, de Perrot, M, Pepper, M S (2006). Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma. J. Clin. Pathol. 59: 191-195 [Abstract] [Full Text]  
• Jaiswal, K., Lopez-Guzman, C., Souza, R. F., Spechler, S. J., Sarosi, G. A. Jr (2006). Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G335-G342 [Abstract] [Full Text]  
• Cook, M. B., Wild, C. P., Forman, D. (2005). A Systematic Review and Meta-Analysis of the Sex Ratio for Barrett's Esophagus, Erosive Reflux Disease, and Nonerosive Reflux Disease. Am J Epidemiol 162: 1050-1061 [Abstract] [Full Text]  
• Souza, R. F., Spechler, S. J. (2005). Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach. CA Cancer J Clin 55: 334-351 [Abstract] [Full Text]  
• Casson, A. G., Zheng, Z., Evans, S. C., Veugelers, P. J., Porter, G. A., Guernsey, D. L. (2005). Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 26: 1536-1541 [Abstract] [Full Text]  
• von Rahden, B. H.A., Stein, H. J., Puhringer, F., Koch, I., Langer, R., Piontek, G., Siewert, J. R., Hofler, H., Sarbia, M. (2005). Coexpression of Cyclooxygenases (COX-1, COX-2) and Vascular Endothelial Growth Factors (VEGF-A, VEGF-C) in Esophageal Adenocarcinoma. Cancer Res. 65: 5038-5044 [Abstract] [Full Text]  
• Deviere, J (2005). Barrett's oesophagus: the new endoscopic modalities have a future. Gut 54: i33-i37 [Abstract] [Full Text]  
• Bergman, J J G H M, Tytgat, G N J (2005). New developments in the endoscopic surveillance of Barrett's oesophagus. Gut 54: i38-i42 [Abstract] [Full Text]  
• Hage, M, Siersema, P D, van Dekken, H, Steyerberg, E W, Haringsma, J, van de Vrie, W, Grool, T E, van Veen, R L P, Sterenborg, H J C M, Kuipers, E J (2004). 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 53: 785-790 [Abstract] [Full Text]  
• Koshy, M., Esiashvilli, N., Landry, J. C., Thomas, C. R. Jr., Matthews, R. H. (2004). Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches. The Oncologist 9: 137-146 [Abstract] [Full Text]  
• Abbas, A. E., Deschamps, C., Cassivi, S. D., Allen, M. S., Nichols, F. C. III, Miller, D. L., Pairolero, P. C. (2004). Barrett's esophagus: the role of laparoscopic fundoplication. Ann. Thorac. Surg. 77: 393-396 [Abstract] [Full Text]  
• Enzinger, P. C., Mayer, R. J. (2003). Esophageal Cancer. NEJM 349: 2241-2252 [Full Text]  
• Luedtke, P., Levine, M. S., Rubesin, S. E., Weinstein, D. S., Laufer, I. (2003). Radiologic Diagnosis of Benign Esophageal Strictures: A Pattern Approach. RadioGraphics 23: 897-909 [Abstract] [Full Text]  
• Spechler, S. J. (2003). Managing Barrett's oesophagus. BMJ 326: 892-894 [Full Text]  
• Metz, D. C., Alberts, D. S. (2003). Gastrointestinal Cancer Prevention in the United States: The Road Ahead. Cancer Epidemiol. Biomarkers Prev. 12: 81-83 [Full Text]  
• Spechler, S. J. (2003). A 59-Year-Old Woman With Gastroesophageal Reflux Disease and Barrett Esophagus. JAMA 289: 466-475 [Full Text]